Fangzhou Inc. Garners Industry Recognition as an Innovator in AI Technology

GUANGZHOU, China, Oct. 30, 2024 /PRNewswire/ — Fangzhou Inc. (“Fangzhou”) (06086.HK), a leader in Internet healthcare solutions, was featured on the 2024 Guangdong “AI Catalyst” Enterprise Billboard at the 2024 Guangdong-Hong Kong-Macao Greater Bay Area Artificial Intelligence Industry Conference. The Company was selected for its significant contributions in advancing the use of AI technology in the field of online healthcare and chronic disease management. Fangzhou’s platform leverages advanced technologies, including AI assistants and big data, with the goal of enhancing the efficiency of its chronic disease management services and providing patients and doctors with a better user experience.

Mr. Xie Fangmin, CEO of Fangzhou, stated, “We are honored to be recognized as an AI technology innovator. This acknowledgment reflects our commitment to improving healthcare through technological advancement and our dedication to providing exceptional service to patients and healthcare providers alike.”

Guangdong at the Forefront of AI Integration

Guangdong has consistently demonstrated its commitment to fostering AI applications across a range of industries and sectors. In May, it introduced the “Measures for Empowering Various Industries with Artificial Intelligence,” aiming to create over 500 AI-driven application scenarios in areas like manufacturing, education, and senior care. This effort continued in October with the “Action Plan for Promoting High-Quality Development of Guangdong’s Life Sciences Industry,” outlining 38 measures to position Guangdong as a leading biotech hub.

About Fangzhou Inc.

Fangzhou Inc. (06086.HK) is China’s leading online chronic disease management platform. With 45.6 million registered users and 217,000 registered doctors on its platform (as of June 30, 2024), the Company provides tailored medical care and precision medicine for a growing population of chronic disease patients. For more details, visit https://investors.jianke.com.

About the Greater Bay Area Artificial Intelligence Industry Conference

The 2024 Guangdong-Hong Kong-Macao Greater Bay Area Artificial Intelligence Industry Conference was held on October 23rd in Nansha, Guangzhou. Under the leadership of the Guangdong Province Department of Science and Technology, the event was organized by the Guangdong Association of Artificial Intelligence Industry, with support from the Smart Manufacturing Committee of the Chinese Association for Artificial Intelligence and Guangzhou University. The conference gathered 11 prominent academicians and over 1,000 leaders from academia and industry to explore AI trends and technological advancements.

Disclaimer: This press release contains forward-looking statements. Actual results may differ materially from those anticipated due to various factors. Readers are cautioned not to place undue reliance on these statements

Media Contact
For further inquiries or interviews, please reach out to:
Xingwei Zhao Associate Director of Public Relations Email: pr@jianke.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/fangzhou-inc-garners-industry-recognition-as-an-innovator-in-ai-technology-302292293.html

SOURCE Fangzhou Inc.

Staff

Recent Posts

Massimo Group Signs Letter of Intent to Acquire 100% of AI technology company FST in Drive to Accelerate Its AI-Powered Mobility and Health Technology Strategy

GARLAND, Texas, Feb. 3, 2026 /PRNewswire/ -- Massimo Group (NASDAQ: MAMO) ("Massimo" or the "Company"),…

6 minutes ago

Baysient Launches iDose® GEN7.0, Expanding Precision Dosing Platform to 16 Inflammatory Disease Indications

Next-Generation Decision Support Software Introduces Predictive Clinical Tools for Gastroenterology, Rheumatology, Dermatology, and PulmonologyFORT MYERS,…

6 minutes ago

From the Founders of Fitbit: Introducing Luffu, Your Guardian for Family Health & Safety

After making personal health accessible to millions with Fitbit, James Park and Eric Friedman announce…

6 minutes ago

Embla Medical hf: Interim Report Q4 and Full Year 2025

COPENHAGEN, Denmark, Feb. 3, 2026 /PRNewswire/ -- Announcement no. 5/2026 Interim Report Q4 and Full…

6 minutes ago

UAE Partners with Colossal Biosciences to Protect Biodiversity and Champion the Future of Life on Earth

The collaboration positions the UAE as a global leader in conservation, driving pioneering initiatives in…

6 minutes ago

Case Reports in Regrowth Announces Publication of Muhammad Qasim Observational Case Report and Invites Medical Review

New York, New York--(Newsfile Corp. - February 3, 2026) - Case Reports in Regrowth today…

36 minutes ago